Bialer’s research interests include:
Pharmacokinetics of new antiepileptic drugs (AEDs) and pharmacokinetic-based design of new antiepileptics and CNS drugs. In this regard he has been utilizing structure pharmacokinetic pharmacodynamic relationship (SPPR) studies to design and develop new CNS drugs with better potency, lack of teratogenicity, and a wide safety margin;
Pharmacokinetic analysis of new drugs, sustained release dosage forms, and novel drug delivery systems (DDS);
Stereospecific pharmacokinetic and pharmacodynamic analysis of chiral drugs;
Pharmacogenetics of CNS drugs;
Pharmacoresistance to AEDs
Area of Interest:
Pharmacokinetics (PK), PK-based-design, epilepsy,neuropathic pain, bipolar disorder, antiepileptics drugs (AEDs), CNS drugs, pharmacogenetics,pharmacoresistance epilepsy